Watchlist Price Alert

Orthofix Medical Inc. (OFIX)

NASDAQ: OFIX · Real-Time Price · USD

12.15

-0.16 (-1.30%)

At close: May 09, 2025, 3:59 PM

11.97

-1.47%

Pre-market: May 12, 2025, 08:01 AM EDT

-1.30% (1D)

Bid	10.6
Market Cap	476.05M
Revenue (ttm)	799.49M
Net Income (ttm)	-126M
EPS (ttm)	-3.3
PE Ratio (ttm)	-3.68
Forward PE	-17.87
Analyst	Buy

Ask	12.56
Volume	497,085
Avg. Volume (20D)	265,190
Open	12.50
Previous Close	12.31
Day's Range	12.07 - 12.77
52-Week Range	10.50 - 20.73
Beta	0.88

About OFIX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol OFIX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for OFIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Orthofix Medical has released their quartely earnings on May 6, 2025:

Revenue of $193.65M exceeds estimates by $2.55M, with 2.67% YoY growth.

EPS of -0.081 exceeds estimates by 0.19, with 75.45% YoY growth.

Why Price Moved

5 days ago

-10.93%

Orthofix Medical shares are trading lower after th... Unlock content with Pro Subscription

6 months ago

+6.53%

Orthofix Medical shares are trading higher after the company reported better-than-expected Q3 financial results and entered into a new-credit agreement worth up to $275 million. Additionally, Stifel upgraded the stock from Hold to Buy and raised its price target from $18 to $24 while Roth MKM raised its price target from $20 to $22.

News

5 days ago · seekingalpha.com

Orthofix Medical Inc. (OFIX) Q1 2025 Earnings Call Transcript

Orthofix Medical Inc. (NASDAQ:OFIX ) Q1 2025 Earnings Conference Call May 6, 2025 8:30 AM ET Company Participants Julie Dewey - Chief Investor Relations and Communications Officer Massimo Calafiore - ...

5 days ago · zacks.com

Orthofix (OFIX) Reports Q1 Loss, Tops Revenue Estimates

Orthofix (OFIX) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.17. This compares to loss of $0.46 per share a year ago.

5 days ago · businesswire.com

Orthofix Reports First Quarter 2025 Financial Results

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the first quarter ended March 31, 2025, u...

1 month ago · businesswire.com

Orthofix Receives 510(k) Clearance and CE Mark for TrueLok Elevate Transverse Bone Transport System

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) cle...

2 months ago · businesswire.com

Orthofix Announces Appointment of Vickie Capps to Board of Directors

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced the appointment of Vickie Capps to the Company's Board of Director...

2 months ago · businesswire.com

Orthofix to Participate in the 37th Annual Roth Conference

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that the Company will participate in the 37th Annual Roth Conferen...

2 months ago · zacks.com

Orthofix (OFIX) Q4 Earnings Lag Estimates

Orthofix (OFIX) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to loss of $0.10 per share a year ago.

2 months ago · businesswire.com

Orthofix Reports Fourth Quarter and Full-Year 2024 Results and Provides 2025 Financial Guidance

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended De...

2 months ago · businesswire.com

Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference